In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you
Companies such as Novo Nordisk and Eli Lilly have sent cease-and-desist letters to parties involved in the manufacture, sale, and distribution of unauthorized GLP-1 products
Micron 37 (3), 208222
Business Type Exporter, Importer, Manufacturer, Distributor, Supplier, Trading Company Employee Count 15 Establishment 1964 Working Days To GST NO 23AJQPK9118E2Z4 Payment Mode Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Cheque, Delivery Point (DP), Telegraphic Transfer (T/T), Others Related Products Explore Related Categories More Products From This Seller Seller Details GST - 23AJQPK9118E2Z4 Indore, Madhya Pradesh CEO Mr
Its legal status reflects the absence of completed clinical trials rather than a safety determination